M&A Deal Summary

ArcherDX Acquires Baby Genes

On January 30, 2019, ArcherDX acquired healthcare services company Baby Genes

Acquisition Highlights
  • This is ArcherDX’s 1st transaction in the Healthcare Services sector.
  • This is ArcherDX’s 1st transaction in the United States.
  • This is ArcherDX’s 1st transaction in Colorado.

M&A Deal Summary

Date 2019-01-30
Target Baby Genes
Sector Healthcare Services
Buyer(s) ArcherDX
Deal Type Add-on Acquisition

Target

Baby Genes

Golden, Colorado, United States
Baby Genes, Inc. is a provider of supplemental newborn screening, reflex/confirmatory testing for abnormal newborn screens and pre-conception carrier testing for family planning purposes. Baby Genes is based in Golden, Colorado.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

ArcherDX

Boulder, Colorado, United States

Category Company
Founded 2013
Sector Life Science
DESCRIPTION

ArcherDX is a genomic analysis company democratizing precision oncology through a suite of products and services that are highly accurate, personal, actionable, and easy to use in local settings. ArcherDX was formed in 2013 and is headquartered in Boulder, Colorado.


DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Colorado M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1